In situ radiation sensitivity of recombinant human granulocyte colony-stimulating factor-recruited murine circulating blood and bone marrow progenitors (colony-forming unit [CFU]-Granulocyte-macrophage and CFU-megakaryocyte): Evidence for possible biologic differences between mobilized blood and bone marrow

被引:4
|
作者
Scheding, S [1 ]
Media, JE [1 ]
KuKuruga, MA [1 ]
Nakeff, A [1 ]
机构
[1] WAYNE STATE UNIV, SCH MED, DIV HEMATOL & ONCOL, DETROIT, MI 48201 USA
关键词
D O I
10.1182/blood.V88.2.472.bloodjournal882472
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Increasing evidence especially stemming from peripheral blood progenitor transplantation studies points to a possible biologic difference between mobilized blood and bone marrow progenitor cells. The objective of this study was to compare the in situ radiation sensitivity of recombinant human granulocyte colony-stimulating factor (rhG-CSF)-recruited circulating granulopoietic (blood colony-forming unit-granulocyte-macrophage [CFU-GM(blood)]) and megakaryocytopoietic (blood CFU-megakaryocyte [CFU-Meg(blood)]) progenitors, with the nonmobilized fraction remaining in the bone marrow (CFU-GM(femur) and CFU-Meg(femur)). Splenectomized male B6D2F1 mice received 50 mu g/kg/d rhG-CSF daily for 8 days to induce high levels of circulating progenitors, followed by either total body X-irradiation (TBI) or X-irradiation of the chest (CI) with 62.5, 125, 250, or 500 cGy. Progenitor cells were assayed 24 hours after irradiation. circulating CFU-GM and CFU-Meg in the blood were decreased in a dose-dependent fashion by both TBI and CI, with TBI causing greater damage than CI. Average D-0 values for TBI were 53 cGy for CFU-GM(blood) and 40 cGy for CFU-Meg(blood) D-0 values for Ci were 90 cGy for CFU-GM(blood) and 140 cGy for CFU-Meg(blood). As seen for blood progenitor cells, TBI caused a dose-dependent decrease of both CFU-GM(femur) (D-0, 136 cGy) and CFU-Meg(femur) (D-0 148 cGy). However, radiation-induced bone marrow progenitor cell kill was significantly lower when compared with blood progenitors. Despite the fact that circulating blood elements only received a fraction of the total dose administered as CI, the extent of blood progenitor kill caused by CI was higher than the effects of identical TBI doses on bone marrow CFU. The results of this study showed that rhG-CSF-recruited CFU-Meg(blood) and CFU-GM(blood) were considerably more radiosensitive than femoral progenitors, thereby providing novel evidence for a biologic difference between rhG-CSF-recruited peripheral blood progenitors and the nonrecruited bone marrow CFU. (C) 1996 by The American Society of Hematology.
引用
收藏
页码:472 / 478
页数:7
相关论文
共 50 条
  • [1] HEMATOLOGIC EFFECTS OF RECOMBINANT MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ON THE PERIPHERAL-BLOOD AND BONE-MARROW
    ULICH, TR
    DELCASTILLO, J
    MCNIECE, I
    WATSON, L
    YIN, SM
    ANDRESEN, J
    AMERICAN JOURNAL OF PATHOLOGY, 1990, 137 (02): : 369 - 376
  • [2] Long-term marrow reconstitutive ability of autologous grafts in lymphoma patients using peripheral blood mobilized with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor compared to bone marrow
    Benboubker, L
    Cartron, G
    Roingeard, F
    Delain, M
    Degenne, M
    Linassier, C
    Hérault, O
    Truglio, D
    Bout, M
    Petit, A
    Brémond, JL
    Desboisc, I
    Colombat, P
    Binet, C
    Domenech, J
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (01) : 89 - 97
  • [3] BCNU AND AUTOLOGOUS BONE-MARROW (ABM) - QUANTITATION OF HUMAN GRANULOCYTE-MACROPHAGE COLONY-FORMING CELLS (CFU-C)
    PARKER, LM
    TAKVORIAN, T
    HOCHBERG, FH
    CANELLOS, GP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 141 - 141
  • [4] THE USE OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION
    NEMUNAITIS, J
    SINGER, JW
    CANCER INVESTIGATION, 1993, 11 (02) : 224 - 228
  • [5] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING AND BINDING ACTIVITIES OF PURIFIED HUMAN URINARY COLONY-STIMULATING FACTOR TO MURINE AND HUMAN-BONE MARROW-CELLS
    MOTOYOSHI, K
    SUDA, T
    KUSUMOTO, K
    TAKAKU, F
    MIURA, Y
    BLOOD, 1982, 60 (06) : 1378 - 1386
  • [6] USE OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN GRAFT FAILURE AFTER BONE-MARROW TRANSPLANTATION
    NEMUNAITIS, J
    SINGER, JW
    BUCKNER, CD
    DURNAM, D
    EPSTEIN, C
    HILL, R
    STORB, R
    THOMAS, ED
    APPELBAUM, FR
    BLOOD, 1990, 76 (01) : 245 - 253
  • [7] STIMULATION OF HEMATOPOIESIS IN PATIENTS WITH BONE-MARROW FAILURE AND IN PATIENTS WITH MALIGNANCY BY RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
    VADHANRAJ, S
    BUESCHER, S
    LEMAISTRE, A
    KEATING, M
    WALTERS, R
    VENTURA, C
    HITTELMAN, W
    BROXMEYER, HE
    GUTTERMAN, JU
    BLOOD, 1988, 72 (01) : 134 - 141
  • [8] RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PLUS THE BEAM REGIMEN INSTEAD OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    FOUILLARD, L
    GORIN, NC
    LAPORTE, JP
    DOUAY, L
    ISNARD, F
    NAJMAN, A
    LANCET, 1989, 1 (8652): : 1460 - 1460
  • [9] Immune characteristics of bone marrow harvests and peripheral blood products primed by recombinant human granulocyte colony-stimulating factor
    Gao, S.
    Su, L.
    Tan, Y.
    Liu, X.
    Zhao, Y.
    Liu, Y.
    Yu, P.
    Chen, N.
    Han, W.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S134 - S135
  • [10] Bone marrow mononuclear cell count does not predict neutrophil and platelet recovery following autologous bone marrow transplant: Value of the colony-forming unit granulocyte-macrophage (CFU-GM) assay
    AlFiar, F
    Prince, HM
    Imrie, K
    Stewart, AK
    Crump, M
    Keating, A
    CELL TRANSPLANTATION, 1997, 6 (05) : 491 - 495